Complement in allergy and asthma

Current Opinion in Immunology

Volumn 14, Issue 6, 2002, Pages 705-708

  Gerard, Norma P ^a   Gerard, Craig ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; IMMUNOGLOBULIN E; RECEPTOR PROTEIN; COMPLEMENT; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT RECEPTOR; LEUKOCYTE ANTIGEN;

ALLERGY; ASTHMA; COMPLEMENT ACTIVATION; IMMUNE RESPONSE; IN VIVO STUDY; NONHUMAN; REVIEW; SEPSIS; ANIMAL; BIOSYNTHESIS; HYPERSENSITIVITY; IMMUNOLOGY; MOUSE;

ANAPHYLATOXINS; ANIMALS; ANTIGENS, CD; ASTHMA; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HYPERSENSITIVITY; MICE; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; SEPSIS;

EID: 0036888590     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00410-7     Document Type: Review

References (30)

1. Richet CR: Nobel Lecture: Anaphylaxis. URL http://www.nobel.se/medicine/laureates/1913/richet-lecture.html
2. Lambris J.D., Reid K.B., Volanakis J.E. The evolution, structure, biology and pathophysiology of complement. Immunol Today. 20:1999;207-211.
3. Barrington R., Zhang M., Fischer M., Carroll M.C. The role of complement in inflammation and adaptive immunity. Immunol Rev. 180:2001;5-15.
4. Gerard C., Gerard N.P. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol. 12:1994;775-808.
5. Schraufstatter I.U., Trieu K., Sikora L., Sriramarao P., DiScipio R. Complement c3a and c5a induce different signal transduction cascades in endothelial cells. J Immunol. 169:2002;2102-2110.
6. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402:1999;884-888.
7. Gerard N.P., Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature. 349:1991;614-617.
8. Boulay F., Mery L., Tardif M., Brouchon L., Vignais P. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry. 30:1991;2993-2999.
9. Ames R.S., Li Y., Sarau H.M., Nuthulaganti P., Foley J.J., Ellis C., Zeng Z., Su K., Jurewicz A.J., Hertzberg R.P., et al. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem. 271:1996;20231-20234.
10. Crass T., Raffetseder U., Martin U., Grove M., Klos A., Kohl J., Bautsch W. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur J Immunol. 26:1996;1944-1950.
11. Ohno M., Hirata T., Enomoto M., Araki T., Ishimaru H., Takahashi T.A. A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol Immunol. 37:2000;407-412.
12. Cain S.A., Monk P.N. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J Biol Chem. 277:2002;7165-7169. In this paper, the authors identify C5L2 as a C5a-binding protein, which appears not to activate G protein signaling pathways. Understanding the role of C5L2 in C5a-mediated responses remains critical to a full appreciation of the anaphylatoxin's function.
13. Kildsgaard J., Hollmann T.J., Matthews K.W., Bian K., Murad F., Wetsel R.A. Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J Immunol. 165:2000;5406-5409.
14. Takabayashi T., Vannier E., Clark B.D., Margolis N.H., Dinarello C.A., Burke J.F., Gelfand J.A. A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. J Immunol. 156:1996;3455-3460.
15. Fischer W.H., Hugli T.E. Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response. J Immunol. 159:1997;4279-4286.
16. Drouin S.M., Kildsgaard J., Haviland J., Zabner J., Jia H.P., McCray P.B., Tack B.F., Wetsel R.A. Expression of the complement anaphylatoxins C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol. 166:2001;2025-2032.
17. Farzan M., Schnitzler C.E., Vasilieva N., Leung D., Kuhn J., Gerard C., Gerard N.P., Choe H. Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor. J Exp Med. 193:2001;1059-1066.
18. Riedemann N.C., Guo R.F., Neff T.A., Laudes I.J., Keller K.A., Sarma V.J., Markiewski M.M., Mastellos D., Strey C.W., Pierson C.L., et al. Increased C5a receptor expression in sepsis. J Clin Invest. 110:2002;101-108. The authors demonstrate that overproduction of C5a in the sepsis syndrome is a major factor leading to organ failure, bacteremia and mortality.
19. Hopken U.E., Lu B., Gerard N.P., Gerard C. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature. 383:1996;86-89.
20. Larsen G.L., Mitchell B.C., Harper T.B., Henson P.M. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa. Am Rev Respir Dis. 126:1982;306-311.
21. Kikuchi Y., Kaplan A.P. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol. 109:2002;114-118. This clinical research firmly links complement C5a to chronic urticaaria syndrome. This is also the first demonstration of synergy between IgE and the complement system in allergy.
22. Karp C.L., Grupe A., Schadt E., Ewart S.L., Keane-Moore M., Cuomo P.J., Kohl J., Wahl L., Kuperman D., Germer S., et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol. 1:2000;221-226.
23. The Collaborative Study on the Genetics of Asthma (CSGA) . A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet. 15:1997;389-392.
24. Ober C., Cox N.J., Abney M., Di Rienzo A., Lander E.S., Changyaleket B., Gidley H., Kurtz B., Lee J., Nance M., et al. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet. 7:1998;1393-1398.
25. Wjst M., Fischer G., Immervoll T., Jung M., Saar K., Rueschendorf F., Reis A., Ulbrecht M., Gomolka M., Weiss E.H., et al. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics. 58:1999;1-8.
26. Abe M., Shibata K., Akatsu H., Shimizu N., Sakata N., Katsuragi T., Okada H. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats. J Immunol. 167:2001;4651-4660.
27. Humbles A.A., Lu B., Nilsson C.A., Lilly C., Israel E., Fujiwara Y., Gerard N.P., Gerard C. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature. 406:2000;998-1001.
28. Bautsch W., Hoymann H.G., Zhang Q., Meier-Wiedenbach I., Raschke U., Ames R.S., Sohns B., Flemme N., Meyer Z.U., Vilsendorf A., et al. Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma. J Immunol. 165:2000;5401-5405.
29. Krug N., Tschernig T., Erpenbeck V.J., Hohlfeld J.M., Kohl J. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med. 164:2001;1841-1843. This clinical study confirms the linkage of C3a and C5a generation in humans to antigen-challenge in asthmatics.
30. Drouin S.M., Corry D.B., Kildsgaard J., Wetsel R.A. Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J Immunol. 167:2001;4141-4145.